FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. GOOGL
5. MU
6. USO
7. APGE
8. ABBV
9. MSFT
10. IBM

Go back to FundaMental Pharma appoints depression drug developer Dr. Hans Eriksson as Chief Medical Officer to advance its lead treatment-resistant depression candidate
(NASDAQ: CMPS) Delayed: 12.63 --0 (-0%)
Previous Close $12.63    52 Week High $ 
Open $12.63    52 Week Low $ 
Day High $12.63    P/E N/A 
Day Low $12.63    EPS $ 
Volume 3,361